ß÷ß÷Ö±²¥ researchers have received $4.1 million from the Medical Research Future Fund to advance their research into epilepsy treatments made from spider venom proteins.
Led by , the project aims to prove the safety and efficacy of venom-based drugs by testing them on lab-grown brain and heart organoids grown from the cells of epilepsy patients.
The research aims to pave the way for human clinical trials and to establish organoids as a tool that can be used to test experimental treatments and therapies.
The funding has been provided through the MRFF’s Stem Cell Therapies grant scheme.
Media contact
ß÷ß÷Ö±²¥ Communications
communications@uq.edu.au
+61 429 056 139